Skip to main content
. 2015 Dec 4;13(2):1163–1171. doi: 10.3892/mmr.2015.4642

Figure 6.

Figure 6

β-catenin mediates the effects of Wnt5a on pancreatic cancer cells. (A) Western blot analysis. Tumor cells were grown and transfected with β-catenin siRNA and then treated with recombinant Wnt5a protein prior to western blot analysis. (B) Flow cytometric assay of apoptosis. The cells were subjected to flow cytometric analysis to determine the percentage of apoptotic cells. The bar graph shows the results of densitometric analysis of the apoptotic assays. siRNA, small interfering RNA. The values are presented as the mean ± standard deviation. *P<0.05 of recombinant Wnt5a, vs. the control. **P<0.05 of β-catenin siRNA, vs. the control.